Medicure MCUJF
OTC MCUJF
$2.05 +0.03 (+1.49%)
At close: Oct 2, 2026 · 4:00 PM EDT

Medicure (MCUJF) Gains from Sales and Divestitures (2015)

Updated

Medicure (MCUJF) posted Gains from Sales and Divestitures of -$45.41 billion for the quarter ended Dec 31, 2015.

Analysis

Medicure (MCUJF) Gains from Sales and Divestitures (2015) Analysis & Trends

For the year ended Dec 31, 2015, Medicure's Gains from Sales and Divestitures came in at $47,503.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Medicure 213.94 Mn 205.75 Mn 2.31 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2015 -45.41 Bn
Sep 30, 2015 46.40 Bn
Mar 31, 2015 49,004.85
API Access

Medicure Gains from Sales and Divestitures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=MCUJF&period=max&api_key=YOUR_API_KEY